Spire Wealth Management - LANTERN PHARMA INC ownership

LANTERN PHARMA INC's ticker is LTRN and the CUSIP is 51654W101. A total of 26 filers reported holding LANTERN PHARMA INC in Q3 2021. The put-call ratio across all filers is - and the average weighting 0.5%.

Quarter-by-quarter ownership
Spire Wealth Management ownership history of LANTERN PHARMA INC
ValueSharesWeighting
Q2 2022$12,000
-58.6%
2,025
-50.0%
0.00%
-100.0%
Q1 2022$29,000
-9.4%
4,0500.0%0.00%0.0%
Q4 2021$32,000
+166.7%
4,050
+285.7%
0.00%
Q3 2021$12,000
-20.0%
1,0500.0%0.00%
Q2 2021$15,000
-21.1%
1,0500.0%0.00%
-100.0%
Q1 2021$19,0001,0500.00%
Other shareholders
LANTERN PHARMA INC shareholders Q3 2021
NameSharesValueWeighting ↓
SANDERS MORRIS HARRIS LLC 384,228$2,747,0000.54%
CM Management, LLC 33,765$241,0000.20%
WOLFF WIESE MAGANA LLC 36,155$259,0000.17%
Redmond Asset Management, LLC 49,793$356,0000.11%
CARLSON CAPITAL L P 167,300$1,196,0000.08%
NewEdge Advisors, LLC 169,771$1,214,0000.02%
Sigma Planning Corp 17,600$126,0000.00%
Spire Wealth Management 4,050$29,0000.00%
WELLS FARGO & COMPANY/MN 3,558$25,0000.00%
NORTHERN TRUST CORP 12,629$90,0000.00%
View complete list of LANTERN PHARMA INC shareholders